The Cell and Gene Therapy Grants will support the development, delivery and commercialisation of innovative therapies using cell and gene therapies.

The Grants aim to position NSW as a global leader, supporting projects to:

  • reduce the time between gathering evidence of effective treatments to delivering those treatments at scale
  • deliver innovative therapies rapidly, efficiently and effectively
  • engage commercial and industry partners early to rapidly scale up therapies found to be effective.

The Cell and Gene Therapy Grants also aim to build workforce and infrastructure capacity and capability in NSW for research and development in cell and gene therapy.

Funding of up to $5 million is available for projects in the 2018 inaugural round. Research projects should be a maximum of three years duration. Individual​ Grants will be capped at a maximum of $2 million.

Applications

The Application Guidelines outline the eligibility criteria; application process; assessment process; selection criteria; and reporting requirements for the Grants.

For more information, please refer:

Key dates

Applications close: COB, Thursday, 19 April 2018
NSW Health Eligibility Review: April 2018
Independent Panel Review: May 2018
Announcement of successful applicants: July 2018

More information

For more information regarding frequently asked questions, please refer to FAQ: Cell and Gene Therapy Grants. 

Enquiries may be directed to ohmr@doh.health.nsw.gov.au.

Page Updated: Tuesday 27 March 2018